Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
Karen M TuesleyPenelope M WebbMelinda M ProtaniKatrina SpilsburySallie-Anne PearsonMichael D CooryPeter DonovanChristopher B SteerLouise M StewartNirmala PandeyaSusan J JordanPublished in: Journal of the National Cancer Institute (2022)
Use of nitrogen-based bisphosphonates was associated with a reduced risk of endometrioid and serous ovarian cancer. This suggests the potential for use for prevention, although validation of our findings is required.